EPIDEMIOLOGY AND SCREENING FOR BREAST CANCER

2017 ◽  
Vol 63 (3) ◽  
pp. 375-384
Author(s):  
Vladimir Semiglazov ◽  
Vakhtang Merabishvili ◽  
Vladislav Semiglazov ◽  
Aleksandr Komyakhov ◽  
Yevgeniy Demin ◽  
...  

To our estimations annually breast cancer is registered in more than 2 million women in the world (1018% of all malignant tumors). According to the latest edition of the IARC “Cancer in 5 continents” (V. X, IARC Scientific Publication №164) the maximum standardized rate is recorded over 100 0/0000 in Belgium, Italy and France. The minimum standardized rate (less than 40 0/0000) is marked in Cuba, Turkey and Ukraine. Paying attention to the steady growth of primary cases of breast cancer in the world that are in the first place in the structure of cancer, one of the main tasks of cancer control becomes mass periodic examinations of healthy population to detect latent cancer in such stage when it can be cured completely. The purpose of the study is to investigate breast cancer epidemiology at the present stage and to develop an effective program for breast cancer secondary prevention. Materials and methods. In order to perform the study for the preventive realization there were selected the most suitable methods of mass screening of practically healthy women, modified software accumulation, collection and analysis of data, conducted pilot development on the basis of out-patient departments and the Oncology Center of the Moscow District of St. Petersburg.

2011 ◽  
Vol 29 (27_suppl) ◽  
pp. 152-152
Author(s):  
B. M. Blauvelt ◽  
S. K. Podder ◽  
O. Abulkhair ◽  
C. H. Barrios ◽  
C. Huang ◽  
...  

152 Background: Non-Western, non-Caucasian populations comprise 90% of the world’s estimated 3.2 billion women, living mostly in low and middle income nations. While medical advances have greatly reduced breast cancer morbidity and mortality in developed nations, those are on the rise in many low and middle income nations. The purpose of the study was to identify emerging needs and challenges observed by breast cancer thought leaders in diverse regions of the world consisting mainly of lesser developed nations to identify strategies for improving breast cancer control. Methods: 225 breast cancer medical, advocacy and policy leaders from 30 countries in Latin America, Asia, the Middle East/North and South Africa, Canada and Australia participated in this study. The study sample was composed of 203 breast cancer specialists, 12 patient advocates and 10 policy makers. Results: The most salient needs and challenges identified were to: (1) develop nurses trained in breast cancer patient and family care, management, education and clinical research (48%); (2) individualize breast cancer therapy (47%); and (3) improve understanding of the reasons for apparently higher proportions of younger women presenting with more aggressive tumors among these predominantly non-Caucasian populations (45%). Analysis of these and other needs identified evolved into 4 key themes and sub-dimensions involving nurses to improve breast cancer control: Capacity, Research, Advocacy and Access. Conclusions: The most significant need identified by this study was to increase both the capacity and capability of breast cancer nurses. A comprehensive approach to doing this would include: (1) increasing capacity to educate nurses in breast cancer patient education and related care issues in nursing schools and teaching hospitals; (2) working with local medical societies, educational institutions and governmental authorities to enable nurses to work as primary care practitioners; and (3) increasing participation of nurses in breast cancer clinical research, working with clinicians and in collaboration with breast cancer research centers of excellence from around the world.


Author(s):  
Nawfal Alrawi

Cancer is one of the most common diseases around the world and the second leading cause of death after cardiovascular disease. Breast cancer is the most prevalent cancer type among Iraqi women, as it represents the highest percentage of malignant tumors in women until 2018. Therefore, women should be aware of the aggravation of this disease, the importance of the periodic examination for early detection for breast cancer, and following the most appropriate means for the treatment to get recovered and, thus, to reduce mortality. To fight cancer, there is an urgent need to search for new effective anticancer therapies that alter the molecular biology of tumor cells, stimulate the immune system, or specifically deliver chemotherapy factors directly to cancer cells without affecting normal cells and reducing the side effects of treatments. In this context, this paper aimed to highlight the therapeutic approaches used in the current researches of breast cancer treatment. Accumulated evidence showed that medicinal plant extracts, and can serve as anticancer agents. The proposed mechanisms were discussed and presented in this review.


Author(s):  
Robert A. Smith ◽  
Carol E. DeSantis

The epidemiology of breast cancer measures the occurrence of the disease and trends in various populations. Breast cancer is the most common cause of cancer and the leading cause of cancer death in the world. Most risk factors have a modest effect, but lifestyle changes could reduce the risk of breast cancer, and we can also better identify women at greater risk who are candidates for more aggressive prevention and early detection strategies. The absence of an organized health system is a barrier to ensuring that women get the best advice about risk and prevention and identifying those at high risk early to offer tailored prevention and screening. Radiologists can play a greater role in breast care, through support and communication with referring practices, and to insure more complete risk assessment and education for their patients.


2013 ◽  
Vol 55 (3) ◽  
pp. 318 ◽  
Author(s):  
Lawrence Von Karsa ◽  
Silvina Arrossi

In Europe, as in many other regions of the world, breast cancer is a major cause of suffering and death. Early detection of breast cancer by systematic mammography screening can find lesions for which treatment is more effective and generally more favourable for quality of life. Comprehensive quality assurance guidelines for breast cancer screening ba- sed on mammography have been developed in the Europe Against Cancer programme with the aim of maximising screening benefits while minimising adverse effects, such as unnecessary examination or treatment resulting from false-positive screening tests. The present report provides an overview of the European experience in developing and implementing quality assurance guidelines for breast cancer screening. It highlights implications relevant to those regions of the world in which the burden of breast cancer in the coming years will make population-based screening an option for cancer control.


Breast cancer is the most dreadful disease in the world in past few decades. Many women in the world has been affected due to this horrible disease and died. Breast cancer occurs in breast cells, the fatty tissue or the fibrous connective tissue in the breast. Breast cancer is malignant tumors tend to become progressively worse leading to death. Factors such as age genetic mutations and a family’s reordered history in breast cancer can increase the risk of breast cancer. Two types of tumors: Benign: this tumor type is not dangerous for a human body and rarely causes human death. Malignant: this tumor type is more dangerous and causes human death, it is called breast cancer. Machine learning was the boon technique in the fields of the medical industry. By the development of machine learning and data analytics a decision making tool can be made which helps in early detection and diagnosis of cancer tumor in women. This concept is to study and develop a decision based tool to eradicate breast cancer. The prediction system makes use of the ensemble algorithms to detect the cancer at earlier stage. It also differentiates the type of cancer from which the patient is being affected with effective accuracy.


2019 ◽  
Vol 65 (5) ◽  
pp. 664-671
Author(s):  
Ilya Pyatnitskiy ◽  
O. Puchkova ◽  
Viktor Gombolevskiy ◽  
Lyudmila Nizovtsova ◽  
Natalya Vetsheva ◽  
...  

The article presents a literature review of the PubMed database and the Cochrane library, aimed at analyzing the current situation and problems in the field of breast cancer screening in the world and Russia to form an idea of the key elements in organizing an effective screening program in the Russian healthcare system, as well as the possibilities of using new technologies when organizing such programs.


Author(s):  
Dr.Seethal Peenikkal ◽  
Dr.K.Savitha R. Shenoy ◽  
Dr.Sri Nagesh K.A.

Breast Cancer is one of the most common types of malignancy among Indian woman currently. The current increase in the world wide prevalence of this disease suggests an urgent need of detailed analysis, diagnosis and treatment line through Ayurvedic principles. As cancer is least understood in technical terms of Ayurveda, Nidana Panchaka a basic tool to understand and diagnose a Vyadhi, is used to analyze it. Even though a direct diagnostic correlation of breast cancer is not available under the major Vyadhi classifications, it is possible to elicit and formulate Nidana Panchaka based on the references of Sthana Roga, Shopha, Granthi, Arbuda etc. The current article is an effort to formulate Nidana Panchaka for Breast Cancer, from the background of basic principles of Ayurveda, for a better analysis and diagnosis of the Vyadhi.


Sign in / Sign up

Export Citation Format

Share Document